Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.85
-0.25 (-4.10%)
At close: Sep 12, 2025, 4:00 PM EDT
5.86
+0.01 (0.17%)
After-hours: Sep 12, 2025, 6:54 PM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $518.76 million as of September 12, 2025. Its market cap has increased by 58.85% in one year.
Market Cap
518.76M
Enterprise Value
388.79M
1-Year Change
58.85%
Ranking
Category
Stock Price
$5.85
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $518.76M, a decrease of -38.80%. That is a compound annual growth rate of -7.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 518.76M | 26.37% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | 1.43B | 318.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |